These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 2306181)

  • 1. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
    Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
    Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
    Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
    Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
    Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.
    Blute ML; Nativ O; Zincke H; Farrow GM; Therneau T; Lieber MM
    J Urol; 1989 Nov; 142(5):1262-5. PubMed ID: 2810503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
    Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
    Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
    Badalament RA; O'Toole RV; Young DC; Drago JR
    Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
    Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
    Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
    Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
    Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy.
    Gauwitz MD; Pollack A; el-Naggar AK; Terry NH; von Eschenbach AC; Zagars GK
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):821-8. PubMed ID: 8138434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
    Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
    J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.
    Zincke H
    Urology; 1989 May; 33(5 Suppl):27-36. PubMed ID: 2775377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
    Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
    J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy.
    Di Silverio F; D'Eramo G; Buscarini M; Sciarra A; Casale P; Di Nicola S; Loreto A; Seccareccia F; De Vita R
    Eur Urol; 1996; 30(3):316-21. PubMed ID: 8931963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.